Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.

by Anna Curry, Ismat Khatri, Olha Kos, Fang Zhu, Reginald Gorczynski
Published 2017-01-01

Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.

by Reginald M Gorczynski, Zhiqi Chen, Nuray Erin, Ismat Khatri, Anna Podnos
Published 2014-01-01

Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling

by Michael Tang, Jun Diao, Hongtao Gu, Ismat Khatri, Jun Zhao, Mark S. Cattral
Published 2015-12-01

Characterization of CD200 Ectodomain Shedding.

by Karrie K Wong, Fang Zhu, Ismat Khatri, Qiang Huo, David E Spaner, Reginald M Gorczynski
Published 2016-01-01

Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival

by Aaron Prodeus, Marzena Cydzik, Aws Abdul-Wahid, Eric Huang, Ismat Khatri, Reginald Gorczynski, Jean Gariépy
Published 2014-01-01

A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo

by Aaron Prodeus, Amanda Sparkes, Nicholas W. Fischer, Marzena Cydzik, Eric Huang, Ismat Khatri, Ashley Young, Lindsay Woo, Chung Wai Chow, Reginald Gorczynski, Jean Gariépy
Published 2018-09-01